Atom Investors LP Cytokinetics Inc Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $190,769 - $299,149	3,986 New	3,986 $215,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $1.59 Million - $2.97 Million	-103,957 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$20.58 - $28.96 $3.15 Million - $4.43 Million	-152,880 Reduced 59.52%	103,957 $2.25 Million
Q2 2020 Aug 14, 2020	SELL	$11.15 - $24.64 $54,478 - $120,391	-4,886 Reduced 1.87%	256,837 $6.05 Million
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $1.96 Million - $3.66 Million	224,322 Added 599.78%	261,723 $3.09 Million
Q4 2019 Feb 13, 2020	BUY	$7.95 - $11.84 $297,337 - $442,827	37,401 New	37,401 $397,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.76B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.